Abstract
The Ribonuclease (RNase) H is one of the four enzymes encoded by all retroviruses, including HIV. Its main activity is the hydrolysis of the RNA moiety in RNA–DNA hybrids. The RNase H ribonuclease is essential in the retroviral life cycle, since it generates and removes primers needed by the Reverse Transcriptase (RT) for initiation of DNA synthesis. Retroviruses lacking RNase H activity are noninfectious. Despite its importance, RNase H is the only enzyme of HIV not yet targeted by antiretroviral therapy.
Here, we describe functions and mechanisms of RNase H during the HIV life cycle and describe a cleavage assay, which is suitable to determine RNase H activity in samples of various kinds. In this assay, an artificial, fluorescence-labeled RNA–DNA hybrid is cleaved in vitro by an RT/RNase H enzyme. Cleavage products are analyzed by denaturing polyacrylamide gel electrophoresis (PAGE). This assay may be used to detect the RNase H, assess the effect of inhibitors, or even activators, of the RNase H, as we have described, as candidates for novel antiretroviral agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moelling K, Bolognesi DP, Bauer H et al (1971) Association of the viral reverse transcriptase with an enzyme degrading the RNA moiety of RNA-DNA hybrids. Nat New Biol 234:240–243
Hansen J, Schulze T, Mellert W et al (1988) Identification and characterization of HIV-specific RNase H by monoclonal antibody. EMBO J 7:239–243
Temin HM, Mizutani S (1970) RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226:1211–1213
Wöhrl B, Moelling K (1990) Interaction of HIV-1 RNase H with polypurine tract containing RNA-DNA hybrids. Biochem 29: 10141–10147
Nowotny M (2009) Retroviral integrase superfamily: the structural perspective. EMBO Rep 10:144–151
Moelling K (1974) Reverse transcriptase and RNase H: present in a murine virus and in both subunits of an avian virus. Cold Spring Harb Symp Quant Biol 39:969–973
Keller W, Crouch R (1972) Degradation of DNA RNA hybrids by ribonuclease H and DNA polymerases of cellular and viral origin. Proc Natl Acad Sci U S A 69:3360–3364
Malik HS, Eickbush TH (2001) Phylogenetic analysis of ribonuclease H domains suggests a late, chimeric origin of LTR retrotransposable elements and retroviruses. Genome Res 11: 1187–1197
Wöhrl B, Volkmann S, Moelling K (1991) Mutations of a conserved residue within HIV-1 ribonuclease H affects its exo- and endonuclease activities. J Mol Biol 220:801–818
Volkmann S, Wöhrl BM, Tisdale M et al (1993) Enzymatic analysis of two HIV-1 reverse transcriptase mutants with mutations in carboxyl-terminal amino acid residues conserved among retroviral ribonucleases H. J Biol Chem 268:2674–2683
Volkmann S, Jendis J, Frauendorf A et al (1995) Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA. Nucl Acids Res 23:1204–1212
Sarafianos SG, Das K, Tantillo C et al (2001) Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J 20:1449–1461
Moelling K (1974) Characterization of Reverse Transcriptase and RNase H from Friend murine leukemia virus. Virology 62:46–59
Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403–415
Pfeiffer P, Hohn T (1983) Involvement of reverse transcription in the replication of cauliflower mosaic virus: a detailed model and test of some aspects. Cell 33:781–789
Neumann-Haefelin D, Rethwilm A, Bauer G et al (1983) Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol 172:75–86
Ma BG, Chen L, Ji HF et al (2008) Characters of very ancient proteins. Biochem Biophys Res Commun 366:607–611
Kogoma, T., Foster, P.L. (1998) Physiological functions of E. coli RNase HI. In Ribonucleases H, Crouch, R.J., Toulme, J.J. (Eds), pp 39–66. Paris, France: INSERM
Tisdale M, Schulze T, Larder BA et al (1991) Mutations within the RNase H domain of HIV-1 reverse transcriptase abolish virus infectivity. J Gen Virol 72:59–66
Kwok T, Heinrich J, Jung-Shiu J et al (2009) Reduction of gene expression by a hairpin-loop structured oligodeoxynucleotide: alternative to siRNA and antisense. Biochim Biophys Acta 1790:1170–1178
Rausch JW, Le Grice SF (2004) “Binding, bending and bonding”: polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol 36:1752–1766
Moelling K, Abels S, Jendis J et al (2006) Silencing of HIV by hairpin-loop-structured DNA oligonucleotide (siDNA). FEBS Lett 580:3545–3550
Heinrich J, Mathur S, Matskevich AA et al (2009) Oligonucleotide-mediated retroviral RNase H activation leads to reduced HIV-1 titer in patient-derived plasma. AIDS 23: 213–221
Jendis J, Strack B, Moelling K (1998) Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxynucleotide TFO A. AIDS Res Hum Retroviruses 14:999–1005
Matskevich AA, Ziogas A, Heinrich J et al (2006) Short partially double-stranded oligodeoxynucleotide induces reverse transcriptase/RNase H-mediated cleavage of HIV RNA and contributes to abrogation of infectivity of virions. AIDS Res Hum Retroviruses 22: 1220–1230
Giovannangeli C, Hélène C (1997) Progress in developments of triplex-based strategies. Antisense Nucleic Acid Drug Dev 7:413–421
ten Asbroek AL, van Groenigen M, Nooij M et al (2002) The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides. Eur J Biochem 269: 583–592
Crow YJ, Leitch A, Hayward BE et al (2006) Mutations in genes encoding ribonucleases H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection. Nat Genet 38:910–916
Cerritelli SM, Frovola EG, Feng C et al (2003) Failure to produce mitochondrial DNA results in embryonic lethality in Rnaseh1 null mice. Mol Cell 11:807–815
Good L (2003) Translation repression by antisense sequences. Cell Mol Life Sci 60:854–861
Song JJ, Smith SK, Hannon GJ et al (2004) Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305: 1434–1437
Moelling K, Matskevich A, Jung J-S (2006) Relationship between retroviral replication and RNA interference machineries. Cold Spring Harb Symp on Quant Biol 71:365–368
Wang Y, Juranek S, Li H (2008) Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature 456:921–926
Chung S, Himmel DM, Jiang JK et al (2011) Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptaseassociated ribonuclease H. J Med Chem 54:4462–4474
Nakagawa Y, Tayama K (1998) Mechanism of mitochondrial dysfunction and cytotoxicity induced by tropolones in isolated rat hepatocytes. Chem Biol Interact 116:45–60
Klumpp K, Hang JQ, Rajendran S et al (2003) Two-metal ion mechanism of RNA cleavage by HIV RNase H and mechanism-based design of selective HIV RNase H inhibitors. Nucleic Acids Res 31:6852–6859
Shaw-Reid CA, Munshi V, Graham P et al (2003) Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid. J Biol Chem 278:2777–2780
Budihas SR, Gorshkova I, Gaidamakov S et al (2005) Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones. Nucleic Acids Res 33:1249–1256
Wendeler M, Lee HF, Bermingham A et al (2008) Vinylogous ureas as a novel class of inhibitors of reverse transcriptase-associated ribonuclease H activity. ACS Chem Biol 3:635–644
Chung S, Wendeler M, Rausch JW et al (2010) Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H. Antimicrob Agents Chemother 54:3913–3921
Lansdon EB, Liu Q, Leavitt SA et al (2011) Structural and binding analysis of pyrimidinol carboxylic acid and N-hydroxy quinazolinedione HIV-1 RNase H inhibitors. Antimicrob Agents Chemother 55:2905–2915
Novina CD, Murray MF, Dykxhoorn DM et al (2002) siRNA-directed inhibition of HIV-1 infection. Nat Med 8:681–686
Matzen K, Elzaouk L, Matskevich AA et al (2007) RNase H-mediated retrovirus destruction in vivo triggered by oligodeoxynucleotides. Nat Biotechnol 25:669–674
Wittmer-Elzaouk L, Jung-Shiu J, Heinrich J et al (2009) Retroviral self-inactivation in the mouse vagina induced by short DNA. Antiviral Res 82:22–28
Heinrich J, Schols D, Moelling K (2011) A short hairpin loop-structured oligodeoxynucleotide targeting the virion-associated RNase H of HIV inhibits HIV production in cell culture and in huPBL-SCID mice. Intervirology 55:242–246
Simpson, R.J. (2002) Proteins and Proteomics. A Laboratory Manual. p. 177. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
Loya S, Hizi A (1993) The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses. J Biol Chem 268: 9323–9328
Volkmann S, Dannull J, Moelling K (1993) The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides. Biochimie 75:71–78
Acknowledgements
KM gratefully acknowledges the support of this work by the Institute for Advanced Study at Princeton, USA. FB would like to thank Prof. Peter H. Seeberger (Max Planck Institute of Colloids and Interfaces) for his generous support.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Moelling, K., Broecker, F., Kerrigan, J.E. (2014). RNase H: Specificity, Mechanisms of Action, and Antiviral Target. In: Vicenzi, E., Poli, G. (eds) Human Retroviruses. Methods in Molecular Biology, vol 1087. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-670-2_7
Download citation
DOI: https://doi.org/10.1007/978-1-62703-670-2_7
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-669-6
Online ISBN: 978-1-62703-670-2
eBook Packages: Springer Protocols